PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 24.75
-0.25 (-1.00%)
At close: Dec 5, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 816.54 million as of December 5, 2025. Its market cap has decreased by -8.82% in one year.
Market Cap
816.54M
Enterprise Value
848.87M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.75
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 816.54M, a decrease of -68.48%. That is a compound annual growth rate of -22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 824.79M | -11.95% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 268.47B |
| Novartis AG | 203.78B |
| Lonza Group AG | 38.88B |
| Galderma Group AG | 38.74B |
| Alcon | 31.21B |
| Sandoz Group AG | 24.68B |
| Straumann Holding AG | 14.49B |
| Sonova Holding AG | 11.82B |